NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines ) ? Dermatofibrosarcoma Protuberans Version 1.2019 — August 31, 2018 NCCN Continue Version 1.2019, 08/31/18 ? National Comprehensive Cancer Network, Inc. 2018, All rights reserved. The NCCN Guidelines and this illustration may not be reproduced in any form without the express written permission of NCCN . ? ? Printed by Maria Chen on 9/4/2018 10:27:25 PM. For personal use only. Not approved for distribution. Copyright ? 2018 National Comprehensive Cancer Network, Inc., All Rights Reserved. NCCN Guidelines Version 1.2019 Dermato?brosarcoma Protuberans NCCN Guidelines Index Table of Contents Discussion **Christopher K. Bichakjian, MD/Chair v University of Michigan Roy Decker, MD, PhD § Yale Cancer Center/ Kishwer S. Nehal, MD v ? Memorial Sloan Kettering Cancer Center Rogel Cancer Center Smilow Cancer Hospital Paul Nghiem, MD, PhD v Fred Hutchinson Cancer Research Center/Seattle Cancer Care Alliance Sumaira Z. Aasi, MD v Stanford Cancer Institute Dominick DiMaio, MD ≠ Fred Hutchinson Cancer Research Center/ Seattle Cancer Care Alliance Murad Alam, MD ? ? z Robert H. Lurie Comprehensive Cancer Center of Northwestern University Igor Puzanov, MD ? Roswell Park Cancer Institute Je?rey M. Farma, MD ? Fox Chase Cancer Center Chrysalyne D. Schmults, MD v ? Dana-Farber/Brigham and Women’s Cancer Center Kris Fisher, MD v ≠ St. Jude Children’s Research Hospital/University of Tennessee Health Science Center James S. Andersen, MD ? ? City of Hope Comprehensive Cancer Center Aleksandar Sekulic, MD, PhD ? Mayo Clinic Cancer Center Rachel Blitzblau, MD, PhD § Duke Cancer Institute Karthik Ghosh, MD T Mayo Clinic Cancer Cen